Analysts expect Mimedx Group, Inc. to report revenue of 71.12 M for Q3 26, against a range of 64.73 M to 77.50 M. The most recent reported quarter, Q2 26, came in at 64.36 M, a 4.8% beat against the 61.43 M consensus.
| Metric | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 39.60 M | 40.77 M | 45.68 M | 49.02 M | 51.80 M | 53.37 M | 57.34 M | 64.43 M | 69.88 M | 72.61 M | 76.41 M | 84.06 M | 92.91 M | 88.20 M | 98.61 M | 113.72 M | 118.09 M | 58.99 M | 64.36 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 38.00 M | 46.57 M | 49.89 M | 50.93 M | 51.73 M | 59.25 M | 62.00 M | 65.15 M | 78.12 M | 78.31 M | 83.77 M | 92.84 M | 88.30 M | 84.49 M | 96.38 M | 112.06 M | 111.41 M | 72.07 M | 64.47 M | 77.50 M | 83.30 M | 85.46 M | 93.11 M | 84.04 M | 99.29 M | 93.84 M | 103.96 M | ||||||||||
| Low Estimate | 33.40 M | 40.34 M | 43.48 M | 43.99 M | 48.10 M | 50.95 M | 53.68 M | 56.20 M | 72.57 M | 71.97 M | 73.43 M | 77.41 M | 79.72 M | 78.18 M | 88.91 M | 100.28 M | 91.51 M | 66.21 M | 58.40 M | 64.73 M | 73.96 M | 76.98 M | 81.80 M | 75.97 M | 84.61 M | 77.51 M | 89.60 M | ||||||||||
| Consensus Estimate | 35.70 M | 43.46 M | 46.69 M | 47.46 M | 49.92 M | 55.10 M | 57.84 M | 60.67 M | 75.34 M | 75.14 M | 78.60 M | 85.12 M | 84.01 M | 81.34 M | 92.64 M | 106.17 M | 101.46 M | 69.14 M | 61.43 M | 71.12 M | 78.63 M | 81.22 M | 87.46 M | 80.00 M | 91.95 M | 85.68 M | 96.78 M |
Analysts expect Mimedx Group, Inc. to report earnings per share of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at -0.10, a 100.0% miss against the -0.05 consensus.
| Metric | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.03 | 0.04 | 0.05 | 0.06 | 0.07 | 0.04 | 0.05 | 0.06 | 0.07 | 0.07 | 0.07 | 0.05 | 0.05 | 0.05 | 0.06 | 0.11 | 0.10 | -0.07 | -0.10 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.03 | 0.03 | 0.04 | 0.06 | 0.05 | 0.05 | 0.05 | 0.04 | 0.07 | 0.06 | 0.08 | 0.04 | 0.07 | 0.05 | 0.05 | 0.10 | 0.10 | -0.03 | -0.05 | 0.00 | 0.03 | 0.02 | 0.03 | 0.04 | 0.06 | 0.02 | 0.04 | ||||||||||
| Low Estimate | 0.03 | 0.03 | 0.04 | 0.06 | 0.05 | 0.05 | 0.05 | 0.04 | 0.07 | 0.06 | 0.06 | 0.04 | 0.07 | 0.05 | 0.05 | 0.08 | 0.08 | -0.03 | -0.05 | 0.00 | 0.03 | 0.02 | 0.03 | 0.04 | 0.06 | 0.02 | 0.04 | ||||||||||
| Consensus Estimate | 0.03 | 0.03 | 0.04 | 0.06 | 0.05 | 0.05 | 0.05 | 0.04 | 0.07 | 0.06 | 0.07 | 0.04 | 0.07 | 0.05 | 0.05 | 0.09 | 0.09 | -0.03 | -0.05 | 0.00 | 0.03 | 0.02 | 0.03 | 0.04 | 0.06 | 0.02 | 0.04 |
Pull Wall Street consensus for Mimedx Group, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=MDXG&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "MDXG", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=MDXG&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();